There’s a ray of hope for all those women suffering from breast cancer. A new drug may help thousands of patients to get relief from the deadly cancer, as this drug is much more effective than a standard treatment.
The prescribed breast cancer drug, Arimidex, was first approved in Scotland for use by post-menopausal women with early breast cancer.
Arimidex, is an aromatase inhibitor that helps treat breast cancer by blocking production of oestrogen in the adrenal gland. The drug, is being hailed as the new gold standard therapy after surgery. The risk of the disease returning is also reduced by almost half with the use of this drug.
The author of the study, Professor Walter Jonat, said: “By changing treatment, their chances of beating the disease and living longer cancer free can be greatly improved, giving them more confidence for the future”.
The research published in the Lancet Oncology found that women with early breast cancer who switched to Arimidex after using the standard drug, Tamoxifen, for 2 to 2 years, after the surgery, reduced their chances of dying by 29%.
Patients in England and Wales can also get this drug by the end of the year, as it is being considered for approval.
Related posts:
